Drug
2% lidocaine gel
2% lidocaine gel is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
80%(4 trials)
Phase Distribution
Ph phase_2
1
17%
Ph not_applicable
5
83%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(5)
Detailed Status
Completed5
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (16.7%)
N/A5 (83.3%)
Trials by Status
completed583%
recruiting117%
Recent Activity
1 active trials
Showing 5 of 6
recruitingnot_applicable
2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy
NCT06420388
completednot_applicable
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion
NCT01292447
completednot_applicable
Cervical Lidocaine for Intrauterine Device Insertion Pain
NCT01411995
completednot_applicable
Intracervical Lidocaine Gel for IUD Insertional Pain
NCT01214161
completedphase_2
A Study to Assess the Ability of 2% Lidocaine Gel to Reduce the Discomfort of Urethral Catheterization
NCT01690767
Clinical Trials (6)
Showing 6 of 6 trials
NCT06420388Not Applicable
2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy
NCT01292447Not Applicable
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion
NCT01411995Not Applicable
Cervical Lidocaine for Intrauterine Device Insertion Pain
NCT01214161Not Applicable
Intracervical Lidocaine Gel for IUD Insertional Pain
NCT01690767Phase 2
A Study to Assess the Ability of 2% Lidocaine Gel to Reduce the Discomfort of Urethral Catheterization
NCT01612156Not Applicable
Lubricant Versus Lidocaine Gel for Pain Control During Urodynamics
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6